Medical Educational Resource
We're accelerating the delivery of treatments and cures.
An FDA-approved option for your patients with gMG
Activity Snapshot
Activity Type:
Live, Virtual Webinar
Release Date:
Tuesday, December 16, 2025
Sponsor Information:
This Industry Update Webinar is sponsored by Johnson & Johnson. MDA is providing this resource as an educational opportunity for the neuromuscular disease community. This program is not sponsored, endorsed, or accredited by MDA
Activity Overview:
Please join us as we review the pivotal trial and on-going open label extension data for this FDA-
approved treatment, and to learn if it could be right for your appropriate patients with
generalized myasthenia gravis (gMG).
Please see the full Prescribing Information and Medication Guide for IMAAVY™.
12:00 pm est.
Duration: 30 minutes
